This is the first study to demonstrate that p52, a major component of non-canonical NF-κB signaling, may be an independent prognostic factor for epithelial ovarian cancer, particularly high-grade serous ovarian cancer. The gene discussed is NFKB1; the disease is ovarian serous adenocarcinoma.